BA
Belma Alispahic
Head Of Business Development at Analysismode
View Belma's Contact Info for Free. Sign Up and Get 50 Free Contacts Per Month.Get Started for Free
Work Experience
Jun 2021 - Present · 3 years and 6 months
Head Of Business Development
Oct 2021 - Present · 3 years and 2 months
Research Collaborator
Jun 2021 - Oct 2021 · 4 months
Partnerships And Sponsorship Team Lead
Jun 2023 - Present · 1 years and 6 months
Company Details
11-50 Employees
Revolutionizing Bioprocessing Through AI Precision We develop our solutions to empower scientists, researchers, and industry leaders with SimCell, our AI-driven bioprocess modeling solution. By simplifying the complexities of optimization, enhancing efficiency, and strategically leveraging digital process twins, we aim to transform challenges into opportunities. AnalysisMode envisions a future where SimCell stands as the undisputed leader in AI-driven precision for bioprocessing, setting the gold standard in digital process twins. We see a landscape transformed by SimCell, where biopharmaceutical companies, research institutions, and industry partners seamlessly integrate our innovative solution into their workflows. At AnalysisMode, our mission is to revolutionize bioprocessing through the relentless pursuit of innovation and excellence. Every day, we are committed to pushing the boundaries of what's achievable in the realm of digital process twins. Our mission is not just about creating cutting-edge technology; it's about shaping a future where bioprocessing is synonymous with precision, speed, and accessibility. We are dedicated to making a lasting impact, one where SimCell is synonymous with the future of bioprocessing through digital process twins.
Year Founded
--
Social Media
Linkedin
Industry
Biotechnology Research
HQ Location
Helsinki, FI
Keywords
--
Discover More About Cleveland Clinic

Find verified contacts of Belma Alispahic in seconds from 700M people profiles. Start now!

No Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.